NCT07576595 Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans
| NCT ID | NCT07576595 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Louisiana State University Health Sciences Center in New Orleans |
| Condition | Lung Cancer Screening |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2025-04-17 |
| Primary Completion | 2029-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2025-04-17 with a primary completion date of 2029-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course.
Eligibility Criteria
Inclusion Criteria: * African American * 20+ pack years of smoking * eligible for or received LDCT screening * current smoker * English speaking Exclusion Criteria: * N/A
Contact & Investigator
Tung Sung Tseng, DrPH, MS
PRINCIPAL INVESTIGATOR
LSUHSC New Orleans
Frequently Asked Questions
Who can join the NCT07576595 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Lung Cancer Screening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07576595 currently recruiting?
Yes, NCT07576595 is actively recruiting participants. Contact the research team at jkassn@lsuhsc.edu for enrollment information.
Where is the NCT07576595 trial being conducted?
This trial is being conducted at New Orleans, United States, New Orleans, United States.
Who is sponsoring the NCT07576595 clinical trial?
NCT07576595 is sponsored by Louisiana State University Health Sciences Center in New Orleans. The principal investigator is Tung Sung Tseng, DrPH, MS at LSUHSC New Orleans. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.